Surface modification of PAMAM dendrimer improves its biocompatibility

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 6, 2012, Pages 815-817

  Ciolkowski, Michal ^a   Petersen, Johannes F ^b   Ficker, Mario ^b   Janaszewska, Anna ^a   Christensen, Jørn B ^b   Klajnert, Barbara ^a   Bryszewska, Maria ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Biocompatibility, Circular dichroism; Hemolysis; PAMAM dendrimer; Surface modification

Indexed keywords

AMINE GROUPS; BASIC SCIENCE; BINDING CONSTANT; CELL VIABILITY; DIMETHYL ITACONATE; EXPERIMENTAL CONDITIONS; FOURTH GENERATION; HEMOLYSIS; HEMOLYTIC ACTIVITY; HUMAN SERUM ALBUMINS; NEUROBLASTOMA CELL LINES; PAMAM DENDRIMER; POLYAMIDOAMINE DENDRIMERS; REDUCED TOXICITY; SECONDARY STRUCTURES; SURFACE GROUPS; SURFACE-MODIFIED;

BIOCOMPATIBILITY; CELL CULTURE; MEDICAL NANOTECHNOLOGY; SURFACE TREATMENT;

DENDRIMERS;

DENDRIMER; HUMAN SERUM ALBUMIN; POLYAMIDOAMINE;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; HEMOLYSIS; MOUSE; NONHUMAN;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL LINE; CELL SURVIVAL; DENDRIMERS; MATERIALS TESTING; MICE; NEURONS; SURFACE PROPERTIES;

EID: 84864083112     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2012.03.009     Document Type: Article

References (13)

1. Tomalia D.A., Frechet J.M.J. Discovery of dendrimers and dendritic polymers: a brief historical perspective. J Polym Sci Part A Polym Chem 2002, 40:2719-2728.
2. Patri A.K., Majoros J., Baker J.R. Dendritic polymer macromolecular carriers for drug delivery. Curr Opin Chem Biol 2002, 6:466-471.
3. Kukowska-Latallo J.F., Bielinska A.U., Johnson J., Spindler R., Tomalia D.A., Baker J.R. Efficient transfer of genetic material into mammalian cells using Starbust polyamidoamine dendrimers. Proc Natl Acad Sci U S A 1996, 93:4897-4902.
4. Langereis S., Dirksen A., Hackeng T.M., van Genderen M.H.P., Meijer E.W. Dendrimers and magnetic resonance imaging. New J Chem 2007, 31:1152-1160.
5. Menjoge A.R., Kannan R.M., Tomalia D.A. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today 2010, 15:171-185.
6. Aillon K.L., Xie Y., El-Gendy N., Berkland C.J., Forrest M.L. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev 2009, 61:457-466.
7. Jain K., Kesharwani P., Gupta U., Jain N.K. Dendrimer toxicity: let's meet the challenge. Int J Pharm 2010, 394:122-142.
8. Janaszewska A., Maczynska K., Matuszko G., Appelhans D., Voit B., Klajnert B., et al. Cytotoxicity of PAMAM, PPI and maltose modified PPI dendrimers in Chinese hamster ovary (CHO) and human ovarian carcinoma (SKOV3) cells. New J Chem 2012, 36:428-437.
9. Svenson S., Tomalia D.A. Dendrimers as nanoparticulate drug carriers. Nanoparticulates as drug carriers 2006, 298. Imperial College Press, London. V.P. Torchilin (Ed.).
10. Tomalia DA, Swanson DR, Huang B, inventors; Dendritic Nanotechnologies Ltd. (US), Tomalia DA, Swanson DR, Huang B, assignees. Heterocycle functionalized dendritic polymers. World Patent WO 2004/069878. 19 August 2004.
11. Froehlich E., Mandeville J.S., Jennings C.J., Sedaghat-Herati R., Tajmir-Riahi H.A. Dendrimers bind human serum albumin. J Phys Chem B 2009, 113:6986-6993.
12. Sekowski S., Buczkowski A., Palecz B., Gabryelak T. Interaction of polyamidoamine (PAMAM) succinamic acid dendrimers generation 4 with human serum albumin. Spectrochim Acta A 2011, 81:706-710.
13. Giri J., Diallo M.S., Simpson A.J., Liu Y., Goddard W.A., Kumar R. Interactions of poly(amidoamine) dendrimers with human serum albumin: binding constants and mechanisms. ACS Nano 2011, 5:3456-3468.